Precision cancer risk prediction for tailored treatment and insurance coverage assessment.

Precision cancer risk prediction for tailored treatment and insurance coverage assessment.

This is also just placeholder text for now

Placeholder text here for now Placeholder text here for now Placeholder text here for now Placeholder text here for now Placeholder text here for now

View Research on RISE

Hereditary Cancer
Risk Assessment Module

Created by genetics experts, the RISE tool is a feasible and effective way to identify
patients for genetic testing in an interdisciplinary breast cancer clinic without a genetic counselor

CLINICALLY VALIDATED

96% agreement with genetic counselors’ assessments

PATIENT FRIENDLY

Completed on a phone in 5 minutes or less

SIMPLE TO IMPLEMENT

Embed a questionnaire link into a text, email or QR code for easy access

EASY TO SCALE

Programs can be launched within days and customized to your workflow

RISE Risk Assessment Results

95%

completion
rate

5

minutes on average
to complete

~86%

of breast cancer patients met
testing criteria

1 National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer. J Clin Oncol. 2017
2 Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011

View the Research

Fill out the form to view more of our research studies on digital tools for genomic medicine.


View the Poster

Fill out the form to view
and download the poster.